论文部分内容阅读
目的:探讨应用血塞通促进高血压脑出血血肿吸收达到的临床效果和安全性。方法:回顾分析2011年4月～2013年2月我院收治的64例高血压脑出血患者的临床资料,随机分为2组,对照组给予常规治疗,观察组在常规治疗的基础上根据出血量在发病后相应的时间给予血塞通静点。治疗2周后观察两组的血肿吸收情况、临床疗效以及不良反应。结果:经2周治疗后复查CT,并观察两组的症状、体征等,2组吸收情况和治疗的总有效率均有显著性差异(p<0.05),只出现1例不良轻微不良反应,减慢静点速度症状缓解,未影响疗程。结论:血塞通用于促进高血压脑出血血肿吸收可以产生理想的临床效果,血肿消退明显,提高疗效,降低高血压脑出血的致死率和致残率,不良反应小,使用安全,值得推广。
Objective: To explore the clinical effect and safety of Xuesaitong on promoting hematoma absorption of hypertensive intracerebral hemorrhage. Methods: The clinical data of 64 patients with hypertensive intracerebral hemorrhage treated in our hospital from April 2011 to February 2013 were retrospectively analyzed. The patients were randomly divided into 2 groups. The control group was given routine treatment. The observation group was treated with hemorrhage The amount of blood in the corresponding time after the onset of Xuesaitongjing. After 2 weeks of treatment, hematoma absorption, clinical efficacy and adverse reactions in both groups were observed. Results: After two weeks of treatment, CT was observed and the symptoms and signs of the two groups were observed. There were significant differences (P <0.05) between the two groups of absorption and the total effective rate of treatment, only one case of adverse minor adverse reactions, Slow down static speed symptoms, did not affect the course of treatment. Conclusion: Xuesaitong can promote the hypertensive intracerebral hemorrhage hematoma absorption can produce the ideal clinical effect, hematoma subsided obviously, improve the curative effect, reduce the lethal rate and morbidity of hypertensive intracerebral hemorrhage, the adverse reaction is small, safe to use, it is worth to popularize.